Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12, 1918

By sjmartinez • March 12, 2024

Wu Y, Sarkissyan M, Ogah O, Kim J, Vadgama JV. Correction: Wu et al. Expression of MALAT1 Promotes Trastuzumab Resistance in HER2 Overexpressing Breast Cancers. Cancers 2020, 12, 1918. Cancers (Basel). 2024 Mar 1;16(5):1026. doi: 10.3390/cancers16051026. Erratum for: Cancers (Basel). 2020 Jul 16;12(7): PMID: 38473438.

Tags: Endocrinology, General Internal Medicine, King Drew Med Ctr, Publications

“It’s Just a Matter of Doing It”: Women Veterans’ Experiences with Changing Behavior for Cardiovascular Risk Reduction

Clair K, Fletcher EH, Oishi A, Schweizer CA, Jackson L, Chanfreau C, Finley EP, Hamilton A, Moin T, Farmer MM, Bean-Mayberry B. "It's Just a[...]

Impact of Medicaid Continuous Glucose Monitor Expansion on Uptake, Glycemic Outcomes, and Engagement Among Adults With Type 2 Diabetes in a Federally Qualified Health Center

Solorzano W, Scarlett LD, Perini Villanueva G, Santiago Mangual K, Santana C, Escobar B, Rubio A, Jackson NJ, Tavares M, Borrell J, Brumley B, Moin[...]

Generalizable, high-throughput image analysis of subcellular structures using dispersion indices

Martin A, Zhang S, Williamson A, Tingley B, Pickus M, Zurakowski D, Nia HT, Shirihai O, Han X, Grinstaff MW. Generalizable, high-throughput image analysis of[...]